NewsWatch: Why the new SEC sheriff could be trouble for companies like Tesla

Merck Asks FDA to Authorize Promising Covid-19 Pill

The filing comes shortly after data from a late-stage study showed that the antiviral drug, molnupiravir, cut the risk of hospitalization or death by about 50% in high-risk people with mild to moderate Covid-19. 

Oct. 11, 2021 at 6:00 a.m. ET

by Jared S. Hopkins

This post was originally published on Market Watch